Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 413 Lymphoma 401 Lymphoma, Non-Hodgkin 337 Leukemia, Lymphocytic, Chronic, B-Cell 302 Lymphoma, Follicular 295 Lymphoma, Mantle-Cell 225 Lymphoma, B-Cell, Marginal Zone 159 Leukemia 119 Lymphoma, B-Cell 112 Burkitt Lymphoma 110 Waldenstrom Macroglobulinemia 99 Precursor Cell Lymphoblastic Leukemia-Lymphoma 90 Recurrence 83 Hodgkin Disease 60 Lymphoma, Large-Cell, Immunoblastic 57 Neoplasms 39 Multiple Myeloma 26 Lymphoma, Large-Cell, Anaplastic 26 Myelodysplastic Syndromes 25 Leukemia, Myeloid, Acute 24 Dendritic Cell Sarcoma, Interdigitating 22 Hematologic Neoplasms 21 Leukemia, Hairy Cell 20 Intraocular Lymphoma 17 Leukemia, Prolymphocytic 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma, T-Cell 14 Neoplasms, Plasma Cell 13 Lymphoproliferative Disorders 12 Hematologic Diseases 12

Interventions

midostaurin 2 selinexor 1 pegfilgrastim 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aggression × Rituximab × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡